Literature DB >> 10451071

Involvement of the zygapophyseal joint in ankylosing spondylitis: relation to the bridging syndesmophyte.

K de Vlam1, H Mielants, E M Veys.   

Abstract

OBJECTIVE: To determine the prevalence of zygapophyseal (ZA) joint ankylosis in ankylosing spondylitis (AS) and the relation of this ankylosis to the presence of bridging syndesmophytes.
METHODS: Roentgenograms of the cervical and lumbar spine of 50 patients with AS were scored by a vertebral body score according to Taylor and a newly developed score for ZA joint involvement.
RESULTS: At the cervical level 22% of the ZA joints were ankylosed and 16% of the levels presented bridging syndesmophytes. In the lumbar spine 22% of ZA joints were ankylosed and 16% of the vertebral levels showed ankylosis in both ZA joints. Bridging syndesmophytes were present in 11% of the vertebral levels. Ankylosis of the ZA joints and bridging syndesmophytes were seen simultaneously in 14% of the cervical levels and in 9% of all lumbar levels. Ankylosed ZA joints were present in 21% of the lumbar levels without bridging syndesmophytes and in 8% of the cervical levels without bridging syndesmophytes. Bridging syndesmophytes at a given level without ankylosis of the respective ZA joint were uncommon: 4 of 201 lumbar levels and 4 of 238 cervical levels. Ankylosis of the ZA joint and presence of bridging syndesmophytes is markedly associated, but in a discordant way.
CONCLUSION: The ZA joint is affected in a major way in AS. Involvement of the ZA joint and the presence of syndesmophytes are related. An asymmetric relation suggests that the ZA joint is primarily involved in AS.

Entities:  

Mesh:

Year:  1999        PMID: 10451071

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Mechanisms of pathologic new bone formation.

Authors:  Kurt de Vlam; Rik J U Lories; Frank P Luyten
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

2.  The relationship between severity and extent of spinal involvement and spinal mobility and physical functioning in patients with ankylosing spondylitis.

Authors:  Taciser Kaya; Fazil Gelal; Rezzan Gunaydin
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

Review 3.  [Imaging in ankylosing spondylitis].

Authors:  J Braun; M Rudwaleit; K G Hermann; R Rau
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

4.  Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?

Authors:  A Wanders; R Landewé; M Dougados; H Mielants; Sj van der Linden; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2005-07       Impact factor: 19.103

Review 5.  Staging of patients with ankylosing spondylitis: a preliminary proposal.

Authors:  J Braun; D van der Heijde; M Dougados; P Emery; M A Khan; J Sieper; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

6.  Lumbosacral radiographic signs in patients with previous enteroarthritis or uroarthritis.

Authors:  A Mannoja; J Pekkola; M Hämäläinen; M Leirisalo-Repo; L Laasonen; L Kivisaari
Journal:  Ann Rheum Dis       Date:  2004-11-11       Impact factor: 19.103

7.  Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.

Authors:  Michael M Ward; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael H Weisman
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

Review 8.  [Immunopathology of ankylosing spondylitis and other spondyloarthritides].

Authors:  H Appel; C Loddenkemper; J Sieper
Journal:  Z Rheumatol       Date:  2008-02       Impact factor: 1.372

Review 9.  [Epidemiology and prognostic aspects of ankylosing spondylitis].

Authors:  J Braun
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

Review 10.  [Imaging in patients with axial spondylarthritis with focus on new bone formation].

Authors:  X Baraliakos; J Braun
Journal:  Z Rheumatol       Date:  2020-02       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.